Aspreva Pharmaceuticals Corporation specializes in late-stage development and commercialization of new drugs for uncommon diseases. They engage in many partnerships with smaller biopharmaceutical companies with promising drug candidates. Aspreva’s expertise is in clinical, regulatory and commercial aspects of specialty drug development